Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jean Hugues, François"'
Autor:
Anne Largeot, Vanessa Klapp, Elodie Viry, Susanne Gonder, Iria Fernandez Botana, Arnaud Blomme, Mohaned Benzarti, Sandrine Pierson, Chloé Duculty, Petra Marttila, Marina Wierz, Ernesto Gargiulo, Giulia Pagano, Ning An, Najla El Hachem, Daniel Perez Hernandez, Supriya Chakraborty, Loic Ysebaert, Jean-Hugues François, Susan Cortez, Guy Berchem, Dimitar G Efremov, Gunnar Dittmar, Martyna Szpakowska, Andy Chevigne, Petr V. Nazarov, Thomas Helleday, Pierre Close, Johannes Meiser, Basile Stamatopoulos, Laurent Désaubry, Jérôme Paggetti, Etienne Moussay
Publikováno v:
HemaSphere, Vol 7, p e52627ab (2023)
Externí odkaz:
https://doaj.org/article/cadb7e0ab439425bb2d02339f658e7b0
Autor:
Alexia Vereertbrugghen, Ana Colado, Ernesto Gargiulo, Raimundo Fernando Bezares, Horacio Fernández Grecco, Gregorio Cordini, Maria del Rosario Custidiano, Jean-Hugues François, Guy Berchem, Mercedes Borge, Jerome Paggetti, Etienne Moussay, Romina Gamberale, Mirta Giordano, Pablo Elías Morande
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Current standard treatment of patients with hairy cell leukemia (HCL), a chronic B-cell neoplasia of low incidence that affects the elderly, is based on the administration of purine analogs such as cladribine. This chemotherapy approach shows satisfa
Externí odkaz:
https://doaj.org/article/8023bcc1246e4bd080357aa16d54a4d1
Autor:
Hannah Wurzer, Liza Filali, Céline Hoffmann, Max Krecke, Andrea Michela Biolato, Jérôme Mastio, Sigrid De Wilde, Jean Hugues François, Anne Largeot, Guy Berchem, Jérôme Paggetti, Etienne Moussay, Clément Thomas
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Natural killer (NK) cells are innate effector lymphocytes with strong antitumor effects against hematologic malignancies such as chronic lymphocytic leukemia (CLL). However, NK cells fail to control CLL progression on the long term. For effective lys
Externí odkaz:
https://doaj.org/article/6022f7d32a004eda80782d5d6124ada7
Autor:
Vic Arendt, Laurence Guillorit, Alain Origer, Nicolas Sauvageot, Michel Vaillant, Aurélie Fischer, Henri Goedertz, Jean-Hugues François, Ivailo Alexiev, Thérèse Staub, Carole Seguin-Devaux
Publikováno v:
PLoS ONE, Vol 14, Iss 5, p e0215570 (2019)
BackgroundAn outbreak of HIV infections among people who inject drugs (PWID) started in 2014 in Luxembourg.ObjectivesWe conducted phylogenetic and epidemiological analyses among the PWID infected with HIV in Luxembourg or attending the supervised dru
Externí odkaz:
https://doaj.org/article/ecc6f4ed053b4095a9665c06c3b439e8
Autor:
Anne Largeot, Vanessa Klapp, Elodie Viry, Susanne Gonder, Iria Fernandez Botana, Arnaud Blomme, Mohaned Benzarti, Sandrine Pierson, Chloé Duculty, Petra Marttila, Marina Wierz, Ernesto Gargiulo, Giulia Pagano, Ning An, Najla El Hachem, Daniel Perez Hermandez, Supriya Chakraborty, Loïc Ysebaert, Jean-Hugues François, Susan Denisse Cortez Clemente, Guy Berchem, Dimitar G Efremov, Gunnar Dittmar, Martyna Szpakowska, Andy Chevigne, Petr V Nazarov, Thomas Helleday, Pierre Close, Johannes Meiser, Basile Stamatopoulos, Laurent Désaubry, Jerome Paggetti, Etienne Moussay
Publikováno v:
Blood Journal.
Dysregulation of mRNA translation, including preferential translation of mRNA with complex 5'-UTRs such as the MYC oncogene, is recognized as an important mechanism in cancer. In this study, we show that both human and murine chronic lymphocytic leuk
Autor:
Marina Wierz, Sandrine Pierson, Nora Chouha, Laurent Désaubry, Jean-Hugues François, Guy Berchem, Jerome Paggetti, Etienne Moussay
Publikováno v:
Haematologica, Vol 103, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/8ee90e57cd1d4aecacf2167cbc13d9cd
Autor:
Thérèse Staub, Michel Kohnen, Tamir Abdelrahman, Vic Arendt, Jean-Hugues François, Esther Calvo Lasso de la Vega, Chantal Tsobo, Christian Michaux, Pierre Braquet, Anke K. Wienecke-Baldacchino
Publikováno v:
Eurosurveillance
We describe four SARS-CoV-2 re-infections with a B.1.351 variant in 2021, in healthcare workers (HCWs) previously infected in 2020, before detection of this variant in Europe. Cases live in France, near the border with Luxembourg, where variants B.1.
Intrinsic Resistance of Chronic Lymphocytic Leukemia Cells to NK Cell-Mediated Lysis Can Be Overcome
Autor:
Hannah, Wurzer, Liza, Filali, Céline, Hoffmann, Max, Krecke, Andrea Michela, Biolato, Jérôme, Mastio, Sigrid, De Wilde, Jean Hugues, François, Anne, Largeot, Guy, Berchem, Jérôme, Paggetti, Etienne, Moussay, Clément, Thomas
Publikováno v:
Frontiers in Immunology
Natural killer (NK) cells are innate effector lymphocytes with strong antitumor effects against hematologic malignancies such as chronic lymphocytic leukemia (CLL). However, NK cells fail to control CLL progression on the long term. For effective lys
Autor:
Ed G. Marins, Cyrielle Nicolaizeau, Phillip Adams, Ellen E. Paxinos, Ellen Vancutsem, Carole Seguin-Devaux, Denis Pierard, Jesse A. Canchola, Tanja Schneider, Jean-Yves Servais, Jean-Hugues François
BACKGROUND AND OBJECTIVES: Measurement of HIV-1 viral load (VL) is necessary to monitor treatment efficacy in patients receiving antiretroviral therapy. We evaluated the performance of the cobas® HIV-1 quantitative nucleic acid test for use on the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebf14bd8c8c8bf3236c6f86066a276fd
https://hdl.handle.net/20.500.14017/2514d356-bf47-4bfb-b55c-cd8132de0e15
https://hdl.handle.net/20.500.14017/2514d356-bf47-4bfb-b55c-cd8132de0e15
Autor:
Angelina Broukou, Vincent Schlesser, Manon Bosseler, Amandine Lequeux, Bassam Janji, Nassera Aouali, Guy Berchem, Tony Kaoma, Jean-Hugues François, Vanessa Marani, Valérie Palissot
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences; Volume 19; Issue 6; Pages: 1551
International Journal of Molecular Sciences; Volume 19; Issue 6; Pages: 1551
The introduction of novel frontline agents in multiple myeloma (MM), like immunomodulatory drugs and proteasome inhibitors, has improved the overall survival of patients. Yet, MM is still not curable, and drug resistance (DR) remains the main challen